Amneal Pharmaceuticals (NYSE:AMRX) is up 6% premarket after the launchof its generic version of Pfizer’s Lyrica (pregabalin capsules) 25 mg, 50, 75, 100, 150, 200, 225 and 300 mg.
The Company has now launched 21 generic products in 2019.
According to IQVIA, U.S. market sales for year ended May 31, 2019 for pregabalin capsules was ~$5.4B.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.